About this trial
In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.
Eligibility criteria
Qualifiers
Male or female aged 18 years or older who undergo upper endoscopy.
Disqualifiers
1)No contact information or invalid contact information.
2) The surveillance interval cannot be determined according to the surveillance guidelines, including no upper gastrointestinal pathology, therapeutic endoscopy or with history of previous gastrectomy, esophagectomy, or ESD, no dysplasia degrees, no biopsy sites, non-epithelial lesions, duodenal lesions, ulcer and so on.
3) Needless for surveillance or others.
4) High-grade intraepithelial neoplasia or cancer of the esophagus or stomach.
Trial design
Treatments tested in this trial
- AI based automatic surveillance (AS) system (ENDOANGEL-AS)
- Manually remind the patients
Treatment groups
Sponsors and collaborators
Renmin Hospital of Wuhan University
Lead sponsor
Shanghai Pudong Hospital
Collaborator
The Eighth Hospital of Wuhan
Collaborator
Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus
Collaborator